FindTrial
Sign In

T Cell Subset Dynamics-Guided Bone Marrow Sparing in Cervical Cancer Radiotherapy

T Cell Subset Dynamics-Guided Bone Marrow Sparing in Cervical Cancer Radiotherapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129401
Enrollment
Unknown
Registered
2026-08-04
Start date
2026-03-18
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

Cervical cancer radiotherapy group:None

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients with cervical cancer confirmed by pathology 2. Receiving pelvic radiotherapy 3. Having complete radiotherapy dosimetry data 4. Having immune monitoring data before radiotherapy and during follow-up ...

Exclusion criteria

Exclusion criteria: 1. Missing immune data 2. Missing important clinical information

Design outcomes

Primary

MeasureTime frame
Peripheral CD4+ T-cell count at 6 months after radiotherapy;—

Secondary

MeasureTime frame
Changes in peripheral T-cell subset counts;—

Countries

China

Contacts

Public ContactXu Haoping

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

xhp11701@rjh.com.cn+86 21 64370045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026